APA (7th ed.) Citation

Rempenault, C., Combe, B., Morel, J., Guilpain, P., Lukas, C., Daïen, C. I., & Tardivon, L. Risk of severe infection associated with immunoglobulin deficiency under rituximab therapy in immune-mediated inflammatory disease. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Rempenault, Claire, Bernard Combe, Jacques Morel, Philippe Guilpain, Cédric Lukas, Claire Immediato Daïen, and Léa Tardivon. Risk of Severe Infection Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune-mediated Inflammatory Disease. BMJ Publishing Group.

MLA (9th ed.) Citation

Rempenault, Claire, et al. Risk of Severe Infection Associated with Immunoglobulin Deficiency Under Rituximab Therapy in Immune-mediated Inflammatory Disease. BMJ Publishing Group.